Expression of type 1 (interferon gamma) and type 2 (interleukin-13, interleukin-5) cytokines at distinct stages of natural killer cell differentiation from progenitor cells

Blood

Volumn 99, Issue 4, 2002, Pages 1273-1281

  Loza, Matthew J ^a   Zamai, Loris ^a   Azzoni, Livio ^a   Rosati, Emanuela ^a   Perussia, Bice ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 5; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL MATURATION; CYTOKINE PRODUCTION; HEMATOPOIETIC STEM CELL; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; STEM CELL;

EID: 0037082470     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.4.1273     Document Type: Article

References (70)

1. Biology of natural killer cells
2. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes
3. An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense: Studies of natural killer and T cell responses in contrasting viral infections
4. Development of Th1 CD4+ T cells through IL-12 produced by Lysteria-induced macrophages
5. The role of interleukin 12 in the immune response, disease and therapy
6. Role of cytokines in the differentiation of CD4+ T-cell subsets in vivo
7. Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor: Relationship with tumor necrosis factor and synergism with immune interferon
8. Immune interferon enhances functional properties of human granulocytes: Role of Fc receptors and effect of lymphotoxin, tumor necrosis factor, and granulocyte-macrophage colony-stimulating factor
9. Cytokine cross-talk between phagocytic cells and lymphocytes: Relevance for differentiation/activation of phagocytic cells and regulation of adaptive immunity
10. Independent regulation of tumor necrosis factor and lympho-toxin production by human peripheral blood lymphocytes
11. Production of hematopoietic colony-stimulating factors by human natural killer cells
12. Activated natural killer cells and interleukin-2 promote granulocytic and megakaryocytic reconstitution after syngeneic bone marrow transplantation in mice
13. Fc gamma R(CD16) interaction with ligand induces Ca2+ mobilization and phosphoinositide turnover in human natural killer cells: Role of Ca2+ in Fc gamma R(CD16)-induced transcription and expression of lymphokine genes
14. Interaction of Fc receptor (CD16) with ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells
15. Activation of B lymphocytes by NK cells
16. Interactions between B lymphocytes and NK cells
17. IL-5 production by NK cells contributes to eosinophil infiltration in a mouse model of allergic inflammation
18. Natural killer cells determine development of allergen-induced eosinophilic airway inflammation in mice
19. IL-13 production by NK cells: IL-13 producing NK and T cells are present in vivo in the absence of IFN-gamma
20. Production of IL-5 by human NK cells and regulation of IL-5 secretion by IL-4, IL-10, and IL-12
21. Definition of a natural killer NKR-P1A+/CD56-/CD16-functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12
22. Requirement for IRF-1 in the microenvironment supporting development of natural killer cells
23. The transcription factor interferon regulatory factor 1 (IRF-1) is important during the maturation of natural killer 1.1 + T cell receptor-alpha/beta+ (NK1 + T) cells, natural killer cells, and intestinal intraepithelial T cells
24. Ontogeny and differentiation of murine natural killer cells and their receptors
25. Generation of lytic natural killer 1.1 +, Ly-49-cells from multipotential murine bone marrow progenitors in a stroma-free culture: Definition of cytokine requirements and developmental intermediates
26. The in vivo effects of steel factor on natural killer lineage cells in murine spleen and bone marrow
27. IL-15 can substitute for the marrow microenvironment in the differentiation of natural killer cells
28. + natural killer cells from CD34+ hematopoietic progenitor cells
29. Differential effects of interleukin-15 and interleukin-2 on differentiation of bipotential natural killer progenitor cells
30. Role of interleukin-2 (IL-2), IL-7, and IL-15 in natural killer cell differentiation from cord blood hematopoietic progenitor cells and from gamma c transduced severe combined immunodeficiency X1 bone marrow cells
31. Induction and regulation of IL-15 expression in murine macrophages
32. Natural killer cell subsets and development
33. Differential regulation of the Janus kinase-STAT pathway and biologic function of IL-13 in primary human NK and T cells: A comparative study with IL-4
34. Differential effects of interleukin-3, interleukin-7, interleukin-15, and granulocyte-macrophage colony stimulating factor in the generation of natural killer and B cells from primitive human hematopoietic progenitors
35. IL-2-dependent generation of natural killer cells from bone marrow: Role of MAC-1-, NK1-1-precursors
36. Growth of murine natural killer cells from bone marrow in vitro: Role of TNF alpha and IFN gamma
37. The generation of natural killer (NK) cells from NK precursor cells in rat long-term bone marrow cultures
38. Generation of human natural killer cells from im-mature progenitors does not require marrow stromal cells
39. Genesis of human oncolytic natural killer cells from primitive CD34+CD33-bone marrow progenitors
40. Enrichment of interleukin-2-responsive natural killer progenitors in human bone marrow
41. Lymphokine requirement for the generation of natural killer cells from CD34+ hematopoietic progenitor cells
42. Fetal liver contains committed NK progenitors, but is not a site for development of CD34+ cells into T cells
43. Natural killer (NK) cell-mediated cytotoxicity: Differential use of TRAIL and Fas ligand by immature and mature primary human NK cells
44. Preferential proliferation of natural killer cells among peripheral blood mononuclear cells co-cultured with B lymphoblastoid cell lines
45. Human neutrofil Fc gamma receptor distribution and structure
46. Gamma interferon and lymphotoxin, released by activated T cells, synergize to inhibit granulocyte/monocyte colony formation
47. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor-gamma/delta+ T lymphocytes, I: Inhibition of the IL-2-dependent proliferation by anti-Kp43 monoclonal antibody
48. The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules
49. Support of human hematopoiesis in long-term bone marrow cultures by murine stromal cells selectively expressing the membrane-bound and secreted forms of the human homolog of the steel gene factor, stem cell factor
50. Multiple color immunofluorescence for cytokine detection at the single cell level
51. Expression of interleukin-5 and granulocyte-macrophage colony-stimulating factor in human peripheral blood mononuclear cells after activation with phorbol myristate acetate
52. Effects of IL-12 on human natural killer cell differentiation
53. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor
54. Natural killer cell differentiation: Insights from knockout and transgenic mouse models and in vitro systems
55. Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15
56. Differentiation of human NK cells into NK1 and NK2 subsets
57. IL-12 directly enhances in vitro murine erythropoiesis in combination with IL-4 and stem cell factor
58. The FLT3 ligand potently and directly stimulates the growth and expansion of primitive murine bone marrow progenitor cells in vitro: Synergistic interactions with interleukin (IL)-11, IL-12, and other hematopoietic growth factors
59. Cytotoxic lymphocyte maturation factor (interleukin 12) is a synergistic growth factor for hematopoietic stem cells
60. Interleukin-12 enhances interleukin-3 dependent multilineage hematopoietic colony formation stimulated by interleukin-11 or steel factor
61. Interleukin-12 enhances peripheral hematopoiesis in vivo
62. IL-12-deficient mice are defective in IFN-gamma production and type 1 cytokine responses
63. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor)
64. Natural killer (NK) cell stimulatory factor or IL-12 has differential effects on the proliferation of TCR-alpha beta+, TCR-gamma delta+ T lymphocytes, and NK cells
65. Gene expression and secretion of cytokines and cytokine receptors from highly purified CD56+ natural killer cells stimulated with interleukin-2, interleukin-7, and interleukin-12
66. Definition of a novel cellular constituent of the bone marrow that regulates the response of immature B cells to B cell antigen receptor engagement
67. Interleukin-13, a T-cell-derived cytokine that regulates human monocyte and B-cell function
68. Characterization of IL-12 receptor beta1 chain (IL-12Rb1)-deficient mice
69. Defective NK cell activity and Th1 response in IL-18-deficient mice
70. Final steps of natural killer cell maturation: A general model for type 1-type 2 differentiation?